ADGRD1 promotes bladder cancer progression and angiogenesis via the PI3K/AKT/mTOR-mediated pro-angiogenic secretome - Poll - MDSpire

ADGRD1 promotes bladder cancer progression and angiogenesis via the PI3K/AKT/mTOR-mediated pro-angiogenic secretome

  • By

  • Chen Li

  • Zhichao Yang

  • Jialei Zhang

  • Xiaodong Yan

  • Hongwei Su

  • May 28, 2026

  • 0 min

Share

Original Source(s)

ADGRD1 promotes bladder cancer progression and angiogenesis via the PI3K/AKT/mTOR-mediated pro-angiogenic secretome

  • by Chen Li, Zhichao Yang, Jialei Zhang, Xiaodong Yan, Hongwei Su

  • May 28, 2026

Related Content

MRI-guided risk stratification for neoadjuvant immunotherapy in rectal cancer

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment

Identification of MTMR2 as an AML-associated candidate biomarker derived from lipid metabolism–related transcriptomic analysis